Product Information

OLOPATADINE HCL 0.2% EYE DROP is a generic product labeled by Chain Drug Marketing Association, priced at $2.9968 per ML under NDC 83324012025. Its NADAC has been published 82 times since Jan 29, 2025.

FDA first approved this application on May 20, 2020.

The High Outlier badge above means this manufacturer's average price in the Olopatadine Hydrochloride Ophthalmic market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

OLOPATADINE HCL 0.2% EYE DROP

Olopatadine Hydrochloride Ophthalmic
$2.9968per ML
High Outlier
OTC

Strength

2 mg/mL

NDC

83324012025

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

OLOPATADINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209752

FDA Approved

5/20/2020

On Market Since

1/1/2021

Pharmacological Classes

Decreased Histamine Release
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist
Histamine-1 Receptor Inhibitor
Mast Cell Stabilizer

Price Statistics

The NADAC for OLOPATADINE HCL 0.2% EYE DROP has been published 82 times since Jan 29, 2025, and over the history we have for it it has declined 18.7%. The table below summarizes its recorded NADAC range and movement.

Current price$2.9968 per ML
All-time high$3.7687 (Mar 12, 2025)
All-time low$2.9954 (Jun 17, 2026)
52-week high$3.6822
52-week low$2.9954
Median price$3.4829
Average price$3.4305
Largest weekly change-5.7% (Apr 23, 2025)
Weeks tracked82
Tracking sinceJan 29, 2025

Price History

1W

+0.0%

1M

+0.0%

3M

-3.2%

6M

-8.3%

1Y

-17.2%

3Y

N/A

5Y

N/A

All

-18.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OLOPATADINE HCL 0.2% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.2% EYE DROP, manufactured by Chain Drug Marketing Association, is $2.9968 per ML (NDC 83324012025), effective Aug 19, 2026.

How has the price of OLOPATADINE HCL 0.2% EYE DROP changed over time?

Over the history we have for it, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has declined 18.7%. It has been tracked across 82 weekly CMS publications since Jan 29, 2025.

What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.2% EYE DROP?

Since Jan 29, 2025, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has ranged from a low of $2.9954 (Jun 17, 2026) to a high of $3.7687 (Mar 12, 2025), with a median of $3.4829 per ML.

Are there cheaper alternatives to OLOPATADINE HCL 0.2% EYE DROP?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLOPATADINE HCL 0.2% EYE DROP in a comparable dosage form, but none are currently priced below it.

Who manufactures OLOPATADINE HCL 0.2% EYE DROP?

OLOPATADINE HCL 0.2% EYE DROP (NDC 83324012025) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.